Paul Tudor Jones Talis Biomedical Corp Transaction History

Tudor Investment Corp Et Al

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $38,100 - $61,700	10,000 New	10,000 $40,000
Q2 2021 Aug 16, 2021	SELL	$9.62 - $14.56 $96,199 - $145,600	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $112,000 - $278,000	10,000 New	10,000 $129,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.9M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.